id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-2271-0008,FDA,FDA-2019-E-2271,Notice of Final Determination and Requirement for Election Letter,Other,Letter(s),2024-03-06T05:00:00Z,2024,3,2024-03-06T05:00:00Z,,2024-03-06T18:46:57Z,,0,0,09000064863f4859
FDA-2019-E-2271-0007,FDA,FDA-2019-E-2271,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2023-07-13T04:00:00Z,2023,7,2023-07-13T04:00:00Z,,2023-07-13T17:57:33Z,,0,0,0900006485c9f74a
FDA-2019-E-2271-0006,FDA,FDA-2019-E-2271,"Determination of Regulatory Review Period for Purposes of Patent Extension; PREVYMIS IV Solution, New Drug Application 209940",Notice,Determinations,2022-11-14T05:00:00Z,2022,11,2022-11-14T05:00:00Z,2023-01-14T04:59:59Z,2022-11-14T16:28:59Z,2022-24719,0,0,09000064854aac1b
FDA-2019-E-2271-0005,FDA,FDA-2019-E-2271,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T16:20:47Z,,0,0,09000064852ce342
FDA-2019-E-2271-0004,FDA,FDA-2019-E-2271,Letter from Office of Patent Legal Administration/ Office of the Deputy Commissioner for Patents to FDA CDER,Other,Letter(s),2022-05-27T04:00:00Z,2022,5,2022-05-27T04:00:00Z,,2022-05-27T18:09:00Z,,0,0,0900006485100826
FDA-2019-E-2271-0003,FDA,FDA-2019-E-2271,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2022-05-27T04:00:00Z,,2022-05-27T17:36:10Z,,0,0,0900006483d31a50
FDA-2019-E-2271-0002,FDA,FDA-2019-E-2271,Patent Extension Application from Millen White Zelano & Branigan PC (on behalf of AiCuris Anti-infective Cures GmbH),Other,Application,2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T16:03:22Z,,0,0,0900006483c4df14
FDA-2019-E-2271-0001,FDA,FDA-2019-E-2271,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T15:58:13Z,,0,0,0900006483c4de33